Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 84

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 84
---
 ​               | $ |  5,456,804 | ​ | ​ | ​ | ​               | $ |    887,122 | ​ | ​ | ​ | ​               | $ |  4,214,558 | ​ | ​ | ​ | ​    | $ | -2,653,448 | ​ | ​ | ​ | ​ | $ |  10,192,134 | ​ | ​ |

Stock and Option Award Valuations: Stock option grant date fair values are calculated based on the Black- Scholes option valuation model as of the date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., expected term, volatility, dividend yield, risk free rate) as of the measurement date. Time-vested RSU grant date fair values are calculated using the stock price as of the date of grant. Adjustments have been made using the stock price as of year-end and as of each date of vest, as applicable. The following table reconciles the amounts reported in the SCT (column (f) above) to the average CAP (column (g) above) to our non-PEO NEOs (as listed above) in the years presented:

| Item                                                                                            | ​ | ​ | 2020 |   |            |   | ​ | ​ | 2021 |   |            |   | ​ | ​ | 2022 |   |            |   | ​ | ​ | 2023 |   |           |   | ​ | ​ | 2024 |   |            |   | ​ |
|:------------------------------------------------------------------------------------------------|:--|:--|:-----|:--|-----------:|:--|:--|:--|:-----|:--|-----------:|:--|:--|:--|:-----|:--|-----------:|:--|:--|:--|:-----|:--|----------:|:--|:--|:--|:-----|:--|-----------:|:--|:--|
| SCT Total                                                                                       | ​ | ​ | ​    | $ |  2,447,635 | ​ | ​ | ​ | ​    | $ |  2,057,810 | ​ | ​ | ​ | ​    | $ |  2,026,308 | ​ | ​ | ​ | ​    | $ | 1,